Gene-environment interactions in lipoprotein metabolism

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 8, Issue 1, 1998, Pages 47-61

  Ordovas, J M ^a   Lopez Miranda, J ^a   Mata, P ^a   Perez Jimenez, F ^a  

^a TUFTS UNIVERSITY   (United States)

Author keywords

Coronary heart disease; Diet; Environment; Genetics; Lipoproteins

Indexed keywords

EID: 0002231104     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (140)

1. Parusse L, Despres JP, Tremblay A, Leblanc C, Talbot J, Allard C, Bouchard C (1989) Genetic and environmental determinants of serum lipids and lipoproteins in French Canadian Families. Arteriosclerosis 9: 308-318
2. Lamon-Fava S, Jimenez D , Christian JC, Fabsitz RR, Reed T, Carmelli D, Castelli WP, Ordovas JM, Wilson PWF, Schaefer EJ (1991) The NHLBI Twin Study: Heritability of apolipoprotein A-I, B, and low density lipoprotein subclasses and concordance for lipoprotein(a). Atherosclerosis 91: 97-106
3. Austin MA, Sandholzer C, Selby JV, Newman B, Krauss RM, Utermann G (1992) Lipoprotein(a) in women twins: Heritability and relationship to apolipoprotein(a) phenotypes. Am J Hum Genet 51: 829-840
4. Boomsma DI, Kaptein A, Kempen HJM, Gevers Leuven JA, Princen HMG (1993) Lipoprotein(a): Relation to other risk factors and genetic heritability. Results from a Dutch parent-twin study. Atherosclerosis 99: 23-33
5. Schuckit MA (1994) A clinical model of genetic influences in alcohol dependence. J Stud Alcohol 55: 5-17
6. Koopmans JR, Boomsma DI (1996) Familial resemblances in alcohol use: genetic or cultural transmission. J Stud Alcohol 57: 19-28
7. Falciglia GA, Norton PA (1994) Evidence for a genetic influence on preference for some foods. J Am Diet Assoc 94: 154-158
8. Ordovas JM, Lopez-Miranda J, Mata P, Perez-Jimenez F, Lichtenstein AH, Schaefer EJ (1995) Gene-diet interaction in determining plasma lipid response to dietary intervention. Atherosclerosis 118: S11-S28
9. Humphries SE, Talmud PJ, Cox C, Sutherland W, Mann J (1996) Genetic factors affecting the consistency and magnitude of changes in plasma cholesterol in response to dietary challenge. Q J Med 89: 671-680
10. Humphries SE, Peacock RE, Talmud PJ (1995) The genetic determinants of plasma cholesterol and response to diet. Clin Endocrinol Metab 9: 797-823
11. Zilversmit DB (1979) Atherosclerosis: A postprandrial phenomenon. Circulation 60: 473-485
12. Cohn JS, McNamara JR, Cohn SD, Ordovas JM, Schaefer EJ (1988) Plasma apolipoprotein changes in the triglyceride-rich lipoprotein fraction of human subjects fed a fat-rich meal. J Lipid Res 29: 925-936
13. Ginsberg HN, Karmally W, Siddiqui M, Holleran S, Tall AR, Rumsey SC, Deckelbaum RJ, Blaner WS, Ramakrishnan R (1994) A dose-response study of the effects of dietary cholesterol on fasting and postprandial lipid and lipoprotein metabolism in healthy young men. Arterioscler Thromb 14: 576-586
14. Grant KI, Marais MP, Dhansay MA (1994) Sucrose in a lipid-rich meal amplifies the postprandial excursion of serum and lipoprotein triglyceride and cholesterol concentrations by decreasing triglyceride clearance. Am J Clin Nutr 59: 853-860
15. Dubois C, Armand M, Azais-Braesco V, Portugal H, Pauli A-M, Bernard P-M, Latgé C, Lafont H, Borel P, Lairon D (1994) Effects of moderate amounts of emulsified dietary fat on postprandial lipemia and lipoproteins in normolipidemic adults. Am J Clin Nutr 60: 374-382
16. Dubois C, Armand M, Mekki N, Portugal H, Pauli A-M, Bernard P-M, Lafont H, Lairon D (1994) Effects of increasing amounts of dietary cholesterol on postprandial lipemia and lipoproteins in human subjects. J Lipid Res 35: 1993-2007
17. Sandström B, Hansen LT, Sorensen A (1994) Pea fiber lowers fasting and postprandial blood triglyceride concentrations in humans. J Nutr 124: 2386-2396
18. Muesing RA, Griffin P, Mitchell P (1995) Corn oil and beef tallow elicit different postprandial responses in triglycerides and cholesterol, but similar changes in constituents of high-density lipoprotein. J Am Coll Nutr 14: 53-60
19. Barr SI, Kottke BA, Mao SJ (1985) Postprandial distribution of apolipoproteins C-II and C-III in normal subjects and patients with mild hypertriglyceridemia: comparison of meals containing corn oil and medium-chain triglyceride oil. Metabolism 34: 983-992
20. Harris WS, Connor WE, Alam N, Illingworth DR (1988) Reduction of postprandial triglyceridemia in humans by dietary n-3 fatty acids. J Lipid Res. 29: 1451-1460
21. Weintraub MS, Zechner R, Brown A, Eisenberg S, Breslow JL (1988) Dietary polyunsaturated fats of the W-6 and W-3 series reduce postprandial lipoprotein levels. Chronic and acute effects of fat saturation on postprandial lipoprotein metabolism. J Clin Invest 82: 1884-1893
22. De Bruin TWA, Brouwer CB, Van Linde-Sibenius Trip M, Jansen H, Erkelens DW (1993) Different postprandial metabolism of olive oil and soybean oil: A possible mechanism of the high-densi-ty lipoprotein conserving effect of olive oil. Am J Clin Nutr 58: 477-483
23. Lichtenstein AH, Ausman LM, Carrasco W, Jenner JL, Gualtieri LJ, Goldin BR, Ordovas JM, Schaefer EJ (1993) Effects of canola, corn, and olive oils on fasting and postprandial plasma lipoproteins in humans as part of a National Cholesterol Education Program step 2 diet. Arterioscler Thromb 13: 1533-1542
24. Salomaa V, Rasi V, Pekkanen J, Jauhiainen M, Vahtera E, Pietinen P, Korhonen H, Kuulasmaa K, Ehnholm C (1993) The effects of saturated fat and n-6 polyunsaturated fat on postprandial lipemia and hemostatic activity. Atherosclerosis 103: 1-11
25. Kane JP (1983) Apolipoprotein B: structural and metabolic heterogeneity. Annu Rev Physiol 45: 637-650
26. Olofsson SO, Bjursell G, Bostrom K, Carlsson P, Elovson J, Protter AA, Reuben MA, Bondjers G (1987) Apolipoprotein B: structure, biosynthesis and role in the lipoprotein assembly process. Atherosclerosis 68: 1-17
27. Deeb SS, Motulsky AG, Albers JJ (1985) A partial cDNA clone for the human apolipoprotein B. Proc Natl Acad Sci USA 82: 4983-4986
28. Blackhart BD, Ludwig EM, Pierotti VR, Caiati L, Onasch MA, Powell L, Pease R, Knott TJ, Chu R, Mahley W, Scott J, McCarthy BJ, Levy-Wilson B (1986) Structure of the human apolipoprotein B gene. J Biol Chem 261: 15364-15367
29. Law S, Lackner KJ, Hospattanakar AV, Anchors JM, Sakaguchi AY, Naylor SL, Brewer HB Jr (1985) Human apolipoprotein B-100: cloning, analysis of liver mRNA, and assignment of the gene to chromosome 2. Proc Natl Acad Sci USA 82: 8340-8344
30. Genest JJ, Ordovas JM, McNamara JR, Robbins AM, Meade T, Cohn SD, Salem D, Wilson PWF, Masharani U, Frossard P, Schaefer EJ (1990) DNA polymorphisms of the apolipoprotein B gene in patients with premature coronary artery disease. Atherosclerosis 82: 7-17
31. Law A, Wallis SC, Powell LM, Pease RJ, Brunt H, Priestley LM, Knott TJ, Scott J, Altman DG, Miller GJ, Rajput J, Miller NE (1986) Common DNA polymorphism within coding sequence of apolipoprotein B gene associated with altered lipid levels. Lancet 1: 1301-1302
32. Berg K (1986) DNA polymorphism at the apolipoprotein B locus is associated with lipoprotein level. Clin Genet 30: 515-520
33. Talmud PJ, Barni N, Kessling AM (1987) Apolipoprotein B gene variants are involved in the determination of serum cholesterol levels: a study in normo- and hyperlipidemic individuals. Atherosclerosis 67: 81-89
34. Hixson JE, McMahan CA, McGill HC Jr, Strong JP, Research Group PDAY (1992) Apo B insertion/deletion polymorphisms are associated with atherosclerosis in young black but not young white males. Arteriosder Thromb 12: 1023-1029
35. Saha N, Tay JSH, Chew LS (1992) Influence of apolipoprotein B signal peptide insertion/deletion polymorphism on serum lipids and apolipoproteins in a Chinese population. Clin Genet 41: 152-156
36. Xu C-F, Tikkanen MJ, Butler R, Huttunen JK, Pietinen P, Humphries S, and Talmud P (1990) Apolipoprotein B signal peptide insertion/deletion polymorphism is associated with Ag epitopes and involved in the determination of serum triglyceride levels. J Lipid Res 31: 1255-1261
37. Aalto-Setälä K, Tikkanen M, Taskinen MR, Nieminen M, Homberg P, Kontula K (1988) XbaI and c/g polymorphism of the apolipoprotein B gene locus are associated with serum choles-terol and LDL cholesterol levels in Finland. Atherosclerosis 74: 47-54
38. Aalto-Setälä K, Kontula K, Mänttäri M, Huttunen J, Manninen V, Koskinen P, Frick HM (1991) DNA polymorphisms of apolipoprotein B and AI/CIII genes and response to gemfibrozil treatment. Clin Pharmacol Ther 50: 208-214
39. Carlsson P, Darnfors C, Olofsson SO, Bjursell G (1986) Analysis of the human apolipoprotein B gene: complete structure of the B74 region. Gene 49: 29-51
40. Berg K, Powell JT, Wallis S, Pease R, Knott TJ, Scott J (1986) Genetic linkage between the antigenic group (Ag) variation and the apolipoprotein B gene: assignment of the Ag locus. Proc Natl Acad Sci USA 83: 7367-7370
41. Dunning AM, Tikkanen MJ, Ehnholm C, Butler R, Humphries SE (1988) Relationships between DNA and protein polymorphisms of apolipoprotein B. Hum Genet 78: 325-329
42. Demant T, Houlston RS, Caslake MJ, Series JJ, Shepherd J, Packard CJ, Humphries SE (1988) The catabolic rate of low density lipoprotein is influenced by variation in the apolipoprotein B gene. J Clin Invest 82: 797-802
43. Houlston RS, Turner PR, Revill J, Lewis B, Humphries SE (1988) The fractional catabolic rate of low density lipoprotein in normal individuals is influenced by variation in the apolipoprotein B gene. Atherosclerosis 71: 81-85
44. Series JJ, Cameron IM, Caslake M, Gaffney D, Packard CJ, Shepherd J (1989) The XbaI polymorphism of the apolipoprotein B gene influences the degradation of low density lipoprotein in vitro. Biochim Biophys Acta 1003: 183-188
45. Tikkanen MJ, Xu C-F, Hamalainen T, Talmud P, Sarna S, Huttunen JK, Pietinen P, Humphries S (1990) XbaI Polymorphism of the apolipoprotein B gene influences plasma lipid response to diet intervention. Clin Genet 37: 327-334
46. Lopez-Miranda J, Ordovas JM, Ostos MA, Marin C, Jansen S, Salas J, Blanco-Molina A, Jimenez-Pereperez JA, Lopez-Segura F, Perez-Jimenez F (1997) Dietary fat clearance in normal subjects is modulated by genetic variation at the apolipoprotein B gene locus. Arterioscler Thromb Vasc Biol (in press)
47. Byrne CD, Wareham NJ, Mistry PK, Phillips DIW, Martensz ND, Halsall D, Talmud PJ, Humphries SE, Hales CN (1996) The association between free fatty acid concentrations and triglyceride-rich lipoproteins in the postprandial state is altered by a common deletion polymorphism of the apo B signal peptide. Atherosclerosis 127: 35-42
48. Régis-Bailly A, Fournier B, Steinmetz J, Gueguen R, Siest G, Visvikis S (1995) Apo B signal peptide insertion deletion polymorphism is involved in postprandial lipoparticles' responses. Atherosclerosis 118: 23-34
49. Boerwinkle E, Chan L (1989) A three codon insertion/deletion polymorphism in the signal peptide region of the human apolipoprotein B gene directly typed by the polymerase chain reaction. Nucleic Acids Res 17: 4003
50. Visvikis S, Cambou JP, Arveiler D, Evans AE, Parra HJ, Aguillon D, Fruchart JC, Siest G, Cambien F (1993) Apolipoprotein B signal peptide polymorphism in patients with myocardial infarction and controls. "The ECTIM study". Hum Genet 90: 561-565
51. Peacock R, Dunning A, Hamsten A, Tornvall P, Humphries S, Talmud P (1992) Apolipoprotein B gene polymorphisms, lipoproteins and coronary atherosclerosis: A study of young myocardial infarction survivors and healthy population-based individuals. Atherosclerosis 92: 151-164
52. Bohn M, Bakken A, Erikssen J, Berg K (1994) The apolipoprotein B signal peptide insertion/deletion polymorphism is not associated with myocardial infarction in Norway. Clin Genet 45: 255-259
53. Xu C-F, Boerwinkle E, Tikkanen MJ, Huttunen JK, Humphries SE (1990) Genetic variation at the apolipoprotein gene loci contribute to response of plasma lipids to dietary change. Genet Epidemiol 7: 261-275
54. Boerwinkle E., Brown SA, Rohrbach K, Gotto AM Jr, Patsch W (1991) Role of apolipoprotein E and B gene variation in determining response of Iipid, Iipoprotein, and apolipoprotein levels to increased dietary cholesterol. Am J Hum Genet 49: 1145-1154
55. Beisiegel U, Weber W, Ihrke G, Herz J, Stanley KK (1989) The LDL-receptor-related protein, LRP, is an apolipoprotein E-binding protein. Nature 341: 162-164
56. Mahley RW (1988) Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240: 622-630
57. Schaefer EJ, Gregg RE, Ghiselli G, Forte TM, Ordovas JM, Zech LA, Lindgren FT, Brewer HB Jr (1986) Familial apolipoprotein E deficiency. J Clin Invest 78: 1206-1219.
58. Davignon J, Gregg RE, Sing CF (1988) Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 8: 1-21
59. Ordovas JM, Litwack-Klein L, Wilson PWF, Schaefer MM, Schaefer EJ (1987) Apolipoprotein E isoform phenotyping methodology and population frequency with identification of apo El and apo E5 isoforms. J Lipid Res 28: 371-380
60. Schaefer EJ, Lamon-Fava S, Johnson S, Ordovas JM, Schaefer MM, Castelli WP, Wilson PWF (1994) Effects of gender and postmenopausal status on the association of apolipoprotein E phenotype with plasma lipoprotein levels: Results from the Framingham Offspring Study. Arterioscler Thromb 14: 1105-1113
61. Sijbrands EJG, Westendorp RGJ, Hoffer MJV, Frants RR, Meinders AE, Souverijn JHM, Leuven JAG, Van der Laarse A, Havekes LM, Smelt AHM (1996) Effect of apolipoprotein E and insulin resistance on VLDL particles in combined hyperlipidemic patients. Atherosclerosis 126: 197-205
62. Valdez R, Howard BV, Stern MP, Haffner SM (1995) Apolipoprotein E polymorphism and insulin levels in a biethnic population. Diabetes Care 18: 992-1000
63. Kesaniemi YA, Ehnholm C, Miettinen TA (1987) Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype. J Clin Invest 80: 578-581
64. Weintraub MS, Eisenberg S, Breslow JL (1987) Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E. J Clin Invest 80: 1571-1577
65. Brown AJ, Roberts DCK (1991) The effect of fasting triacylglyceride concentration and apolipoprotein E polymorphism on postprandial lipemia. Arterioscler Thromb 11: 1737-1744
66. Nikkilä M, Solakivi T, Lehtimäki T, Koivula T, Laippala P, Astrom B (1994) Postprandial plasma lipoprotein changes in relation to apolipoprotein E phenotypes and low density lipoprotein size in men with and without coronary artery disease. Atherosclerosis 106: 149-157
67. Superko HR, Haskell WL (1991) The effect of apolipoprotein E isoform difference on postprandial lipoproteins in patients matched for triglycerides, LDL-cholesterol, and HDL-cholesterol. Artery 18: 315-325
68. Boerwinkle E, Brown S, Sharrett AR, Heiss G, Patsch W (1994) Apolipoprotein E polymorphism influences postprandial retinyl palmitate but not triglyceride concentrations. Am J Hum Genet 54: 341-360
69. Reznik Y, Pousse P, Herrou M, Morello R, Mahoudeau J, Drosdowsky MA, Fradin S (1996) Postprandial lipoprotein metabolism in normotriglyceridemic non insulin-dependent diabetic patients: Influence of apolipoprotein E polymorphism. Metabolism 45: 63-71
70. Orth M, Wahl S, Hanisch M, Friedrich I, Wieland H, Luley C (1996) Clearance of post-prandial lipoproteins in normolipemics: Role of the apolipoprotein E phenotype. Biochim Biophys Acta 1303: 22-30
71. Bergeron N, Havel RJ (1996) Prolonged postprandial responses of lipids and apolipoproteins in triglyceride-rich lipoproteins of individuals expressing an apolipoprotein ∈4 allele. J Clin Invest 97: 65-72
72. Stocks J, Thorn JA, Galton DJ (1992) Lipoprotein lipase genotypes for a common premature termination codon mutation detected by PCR-mediated site-directed mutagenesis and restriction digestion. J Lipid Res 33: 853-857
73. Humphries SE, Fisher R, Mailly F, Peacock R, Talmud P, Karpe F, Hamsten A, Miller GJ (1996) Gene-environment interaction in determining plasma lipids and dietary response: The effect of common mutations in the gene for lipoprotein lipase (D9N and N291S). In: Pennington Biomedical Research Center (ed): Nutrition, Genetics and Heart Disease. LSU Press, Baton Rouge, pp. 279-295
74. Reymer PWA, Groenemeyer BE, Gagne E, Miao L, Appelman EEG, Seidel JC, Kromhout D, Bijvoet SM, Van de Oever K, Bruin T, Hayden MR, Kastelein JJP (1995) A frequently occurring mutation in the lipoprotein lipase gene (Asn291Ser) contributes to the expression of familial combined hyperlipidemia. Hum Mol Genet 4: 1543-1549
75. Hoffer MJV, Bredie SJH, Boomsma DI, Reymer PWA, Kastelein JJP, de Knijff P, Demacker PNM, Stalenhoef AFH, Havekes LM, Frants RR (1996) The lipoprotein lipase (Asn291→Ser) mutation is associated with elevated lipid levels in families with familial combined hyperlipidaemia. Atherosclerosis 119: 159-167
76. Pimstone SN, Gagné SE, Gagné C, Lupien PJ, Gaudet D , Williams RR, Kotze M, Reymer PWA, Defesche JC, Kastelein JJP, Moorjani S, Hayden MR (1995) Mutations in the gene for lipoprotein lipase - A cause for low HDL cholesterol levels in individuals heterozygous for familial hypercholesterolemia. Arterioscler Thromb Vasc Biol 15: 1704-1712
77. Pimstone SN, Clee SM, Gagné SE, Miao L, Zhang HF, Stein EA, Hayden MR (1996) A frequently occurring mutation in the lipoprotein lipase gene (Asn291Ser) results in altered postprandial chylomicron triglyceride and retinyl palmitate response in normolipidemic carriers. J Lipid Res 37: 1675-1684
78. 9 Asn mutation in the lipoprotein lipase gene is associated with increased progression of coronary atherosclerosis. Circulation 94: 1913-1918
79. De Bruin TWA, Mailly F, Van Barlingen HHJJ, Fisher R, Cabezas MC, Talmud P, Dallinga-Thie GM, Humphries SE (1996) Lipoprotein lipase gene mutations D9N N291S in four pedigrees with familial combined hyperlipidaemia. Eur J Clin Invest 26: 631-639
80. Mailly F, Fisher RM, Nicaud V, Luong LA, Evans AE, MarquesVidal P, Luc G, Arveiler D, Bard JM, Poirier O, Talmud PJ, Humphries SE (1996) Association between the LPL-D9N mutation in the lipoprotein lipase gene and plasma lipid traits in myocardial infarction survivors from the ECTIM study. Atherosclerosis 122: 21-28
81. Karathanasis SK (1985) Apolipoprotein multigene family: tandem organization of human apolipoprotein A-I, C-III and A-IV genes. Proc Natl Acad Sci USA 82: 6374-6378
82. Bruns GA, Karathanasis SK, Breslow JL (1984) Human apolipoprotein AI-CIII gene complex is located in chromosome 11. Arteriosclerosis 4: 97-104
83. Ordovas JM, Civeira F, Genest J Jr, Craig S, Robbins AH, Meade T, Pocovi M, Frossard PM, Masharani U, Wilson PW, Salem DN, Ward RH, Schaefer EJ (1991) Restriction fragment length polymorphisms of the apolipoprotein A-I, C-III, A-IV gene locus. Relationships with lipids, apolipoproteins, and premature coronary artery disease. Atherosclerosis 87: 75-86
84. Tybjærg-Hansen A, Nordestgaard BG, Gerdes LU, Færgeman O, Humphries SE (1993) Genetic markers in the apo AI-CIII-AIV gene cluster for combined hyperlipidemia, hypertriglyceridemia, and predisposition to atherosclerosis. Atherosclerosis 100: 157-169
85. Paul-Hayase H, Rosseneu M, Van Bervliet JP, Deslypere JP, Humphries SE (1992) Polymorphisms in the apolipoprotein (apo) AI-CIII-AIV gene cluster: detection of genetic variation determining plasma apo AI, apo CIII and apo AIV concentrations. Hum Genet 88: 439-446
86. Schaefer EJ, Ordovas JM, Law S, Ghiselli G, Kashyap ML, Srivastava LS, Heaton WH, Albers JJ, Connor WE, Lemeshev Y, Segrest J, Brewer HB Jr (1985) Familial apolipoprotein A-I and C-III deficiency, variant II. J Lipid Res 26: 1089-1101
87. Ordovas JM, Cassidy DK, Civeira F, Bisgaier CL, Schaefer EJ (1989) Familial apolipoprotein A-I, C-III and A-IV deficiency and premature atherosclerosis due to deletion of a gene complex on chromosome 11. J Biol Chem 264: 16339-16342
88. Karathanasis SK, Ferris E, Haddad IA (1987) DNA inversion within the apolipoproteins AI/CIII/AIV -encoding gene cluster of certain patients with premature atherosclerosis. Proc Natl Acad Sci USA 84: 7198-7202
89. Jeenah M, Kessling A, Miller N, Humphries SE (1990) G to A substitution in the promoter region of the apolipoprotein AI gene is associated with elevated serum apolipoprotein AI and high density lipoprotein cholesterol concentrations. Mol Biol Med 7: 233-241
90. Pagani F, Sidoli A, Giudici GA, Barenghi L, Vergani C, Baralle FE (1990) Human apolipoprotein A-I gene promoter polymorphism: Association with hyperalphalipoproteinemia. J Lipid Res 31: 1371-1377
91. Sigurdsson G Jr, Gudnason V, Sigurdsson G, Humphries SE (1992) Interaction between a polymorphism of the Apo A-I promoter region and smoking determines plasma levels of HDL and Apo A-I. Arterioscler Thromb 12: 1017-1022
92. Saha N, Tay JSH, Low PS, Humphries SE (1994) Guanidine to adenine (G/A) substitution in the promoter region of the apolipoprotein AI gene is associated with elevated serum apolipoprotein AI levels in Chinese non-smokers. Genet Epidemiol 11: 255-264
93. Xu C-F, Angelico F, Del Ben M, Humphries S (1993) Role of genetic variation at the apo AI-CIII-AIV gene cluster in determining plasma apo AI levels in boys and girls. Genet Epidemiol 10: 113-122
94. Civeira F, Pocovi M, Cenarro A, Garces C, Ordovas JM (1993) Adenine for guanine substitution -78 base pairs to the apolipoprotein (APO) A-I gene: relation with high density Iipoprotein cholesterol and apoA-I concentrations. Clin Genet 44: 307-312
95. Barre DE, Guerra R, Verstraete R, Wang Z, Grundy SM, Cohen JC (1994) Genetic analysis of a polymorphism in the human apolipoprotein A-I gene promoter: effect on plasma HDL-cholesterol levels. J Lipid Res 35: 1292-1296
96. Lopez-Miranda J, Ordovas JM, Espino A, Marin C, Salas J, Lopez-Segura F, Jimenez-Pereperez J, Perez-Jimenez F (1994) Influence of mutation in human apolipoprotein A-I gene promoter on plasma LDL cholesterol response to dietary fat. Lancet 343: 1246-1249
97. Kondo I, Berg K, Drayna DT, Lawn RM (1989) DNA polymorphism at the locus for human cholesteryl ester transfer protein (CETP) is associated with high density Iipoprotein cholesterol and apolipoprotein levels. Clin Genet 35: 49-56
98. Freeman DJ, Packard CJ, Shepherd J, Gaffney D (1990) Polymorphisms in the gene coding for cholesteryl ester transfer protein are related to plasma high-density Iipoprotein cholesterol and transfer protein activity. Clin Sci 79: 575-581
99. Kessling A, Ouellette S, Bouffard O, Chamberland A, Bétard C, Selinger E, Xhignesse M, Lussier-Cacan S, Davignon J (1991) Patterns of association between genetic variability in apolipoprotein (apo) B, apo AI-CIII-AIV, and cholesterol ester transfer protein gene regions and quantitative variation in lipid and Iipoprotein traits: Influence of gender and exogenous hormones. Am J Hum Genet 50: 92-106
100. Tenkanen H, Koskinen P, Kontula K, Aalto-Setälä K, Mänttäri M, Manninen V, Runeberg S-L, Taskinen M-R, Ehnholm C (1991) Polymorphisms of the gene encoding cholesterol ester transfer protein and serum lipoprotein levels in subjects with and without coronary heart disease. Hum Genet 87: 574-578
101. Kaprio J, Ferrell RE, Kottke BA, Sing CF (1989) Smoking and reverse cholesterol transport: evidence for gene-environment interaction. Clin Genet 36: 266-268
102. Mendis S, Shepherd J, Packard CJ, Gaffney D (1990) Genetic variation in the cholesteryl ester transfer protein and apolipoprotein A-I genes and its relation to Coronary Heart Disease in a Sri Lankan population. Atherosclerosis 83: 21-27
103. Freeman DJ, Griffin BA, Holmes AP, Lindsay GM, Gaffney D, Packard CJ, Shepherd J (1994) Regulation of plasma HDL cholesterol and subfraction distribution by genetic and environmental factors: Associations between the Taql B RFLP in the CETP gene and smoking and obesity. Arterioscler Thromb 14: 336-344
104. Kauma H, Savolainen MJ, Heikkilä R, Rantala AO, Lilja M, Reunanen A, Kesäniemi YA (1996) Sex difference in the regulation of plasma high density Iipoprotein cholesterol by genetic and environmental factors. Hum Genet 97: 156-162
105. Fumeron F, Betoulle D, Luc G, Behague I, Ricard B, Poirier O, Jemaa R, Evans A, Arveiler D, Marques-Vidal P, Bard JM, Fruchart JC, Ducimetière P, Apfelbaum M, Cambien F (1995) Alcohol intake modulates the effect of a polymorphism of the cholesteryl ester transfer protein gene on plasma high density Iipoprotein and the risk of myocardial infarction. J Clin Invest 96: 1664-1671
106. Hannuksela ML, Liinamaa MJ, Kesäniemi YA, Savolainen MJ (1994) Relation of polymorphisms in the cholesteryl ester transfer protein gene to transfer protein activity and plasma lipoprotein levels in alcohol drinkers. Atherosclerosis 110: 35-44.
107. Green PH, Glickman RM, Riley JW, Quinet E (1980) Human apolipoprotein A-IV. Intestinal origin and distribution in plasma. J Clin Invest 65: 911-919
108. Goldberg IJ, Scheraldi CA, Yacoub LK, Saxena U, Bisgaier CL (1990) Lipoprotein apoC-II activation of lipoprotein lipase. Modulation by apolipoprotein A-IV. J Biol Chem 265: 4266-4272
109. Steinmetz A, Utermann G (1985) Activation of lecithin/cholesterol acyltransferase by human apolipoprotein A-IV. J Biol Chem 260: 2258-2264
110. Duverger N, Tremp G, Caillaud JM, Emmanuel F, Castro G, Fruchart J, Steinmetz A, Denèfle P (1996) Protection against atherogenesis in mice mediated by human apolipoprotein A-IV. Science 273: 966-968
111. Stein O, Stein Y, Lefevre M, Roheim PS'(1986) The role of apolipoprotein A-IV in reverse cholesterol transport studied with cultured cells and liposomes derived from an ether analog of phosphatidylcholine. Biochim Biophys Acta 878: 7-13
112. Steinmetz A, Barbaras R, Ghalim N, Clavey V, Fruchart JC, Ailhaud G (1990) Human apolipoprotein A-IV binds to apolipoprotein A-I/A-II receptor sites and promotes cholesterol efflux from adipose cells. J Biol Chem 265: 7859-7863
113. Weinberg RB, Patton CS (1990) Binding of human apolipoprotein A-IV to human hepatocellular plasma membranes. Biochim Biophys Acta 1044: 255-261
114. Menzel HJ, Sigurdsson G, Boerwinkle E, Schrangl-Will S, Dieplinger H, Utermann G (1990) Frequency and effect of human apolipoprotein A-IV polymorphism on lipid and lipoprotein levels in an Icelandic population. Hum Genet 84: 344-346
115. de Knijff P, Johansen LG, Rosseneu M, Frants RR, Jespersen J, Havekes LM (1992) Lipoprotein profile of a Greenland Inuit population. Influence of anthropometric variables, Apo E and A4 polymorphism, and lifestyle. Arterioscl Thromb 12: 1371-1379
116. Saha N (1991) Apolipoprotein A-IV polymorphism in Singapore ethnic groups. Hum Hered 41: 47-52
117. Akiyama K. (1989) Population study of apolipoprotein A-IV polymorphism and report of a new variant in Japanese. Hum Hered 39: 302-304
118. Kamboh MI, Williams ER, Law JC, Aston CE, Bunker CH, Ferrell RE, Pollitzer WS (1992) Molecular basis of a unique African variant (A-IV 5) of human apolipoprotein A-IV and its significance in lipid metabolism. Genet Epidemiol 9: 379-388
119. Bai H, Saku K, Liu R, Funke H, Von Eckardstein A, Arakawa K (1993) Polymorphic site study at codon 347 of apolipoprotein A-IV in a Japanese population. Biochim Biophys Acta 1174: 279-281
120. Von Eckardstein A, Funke H, Schulte M, Erren M, Schulte H, Assmann G (1992) Nonsynonymous polymorphic sites in the apolipoprotein (apo) A-IV gene are associated with changes in the concentration of apo B- and apo A-I-containing lipoproteins in a normal population. Am J Hum Genet 50: 1115-1128
121. Kaprio J, Ferrell RE, Kottke BA, Kamboh MI, Sing CF (1991) Effects of polymorphisms in apolipoproteins E, A-IV, and H on quantitative traits related to risk for cardiovascular disease. Arterioscler Thromb 11: 1330-1348
122. Kamboh MI, Hamman RF, Iyengar S, Aston CE, Ferrell RE (1991) Apolipoprotein A-IV polymorphism, and its role in determining variation in lipoprotein-lipid, glucose and insulin levels in normal and non insulin-dependent diabetic individuals. Atherosclerosis 91: 25-34
123. Eichner JE, Kuller LH, Ferrell RE, Kamboh MI (1989) Phenotypic effects of apolipoprotein structural variation on lipid profiles: II. Apolipoprotein A-IV and quantitative lipid measures in the healthy women study. Genet Epidemiol 6: 493-499
124. Menzel HJ, Boerwinkle E, Schrangl-Will S, Utermann G (1988) Human apolipoprotein A-IV polymorphism: frequency and effect on lipid and Iipoprotein levels. Hum Genet 79: 368-372
125. Kamboh MI, Iyengar S, Aston CE, Hamman RF, Ferrell RE (1992) Apolipoprotein A-IV genetic polymorphism and its impact on quantitative traits in normoglycemic and non-insulin-dependent diabetic Hispanics from the San Luis Valley, Colorado. Hum Biol 64: 605-616
126. de Knijff P, Rosseneu M, Beisiegel U, De Keersgieter W, Frants RR, Havekes LM (1988) Apolipoprotein A-IV polymorphism and its effect on plasma lipid and apolipoprotein concentrations. J Lipid Res 29: 1621-1627
127. Crews DE, Kamboh MI, Mancilha-Carvalho JJ, Kottke B (1993) Population genetics of apolipoprotein A-4, E, and H polymorphisms in Yanomami Indians of northwestern Brazil: associations with lipids, lipoproteins, and carbohydrate metabolism. Hum Biol 65: 211-224
128. Hanis CL, Douglas TC, Hewett-Emmett D (1991) Apolipoprotein A-IV protein polymorphism: frequency and effects on lipids, lipoproteins, and apolipoproteins among Mexican-Americans in Starr County, Texas. Hum Genet 86: 323-325
129. Zaiou M, Visvikis S, Gueguen R, Parra H-J, Fruchart JC, Siest G (1994) DNA polymorphisms of human apolipoprotein A-IV gene: frequency and effects on lipid, Iipoprotein and apolipoprotein levels in a French population. Clin Genet 46: 248-254
130. Rotter JI, Bu X, Cantor RM, Warden CH, Brown J, Gray RJ, Blanche PJ, Krauss RM, Lusis AJ (1994) Multiple genes determine LDL particle size phenotype in coronary artery disease families. Circulation 90 (Suppl. I): 509 (Abstract)
131. Campos H, Lopez-Miranda J, Rodriguez C, Albajar M, Schaefer EJ, Ordovas JM (1997) Urbanization elicits a more atherogenic Iipoprotein profile in carriers of the apolipoprotein A-IV-2 allele compared to A-IV-1 homozygotes. Arterioscler Thromb Vasc Biol 17: 1074-1081
132. Cendoroglo M, Lahoz C, McNamara JR, Levy D, Schaefer EJ, Ordovas JM (1996) The apoA-IV (360Gln:His) mutation is a genetic determinant of LDL particle size in the Framingham Offspring Study: interaction with smoking and alcohol. Circulation 94 (Suppl. I): 93 (Abstract)
133. Lopez-Miranda J, Ordovas JM, Jansen S, Marin C, Salas J, LopezSegura F, Ostos MA, Jimenez-Pereperez JA, Blanco A, Martin M, Perez-Jimenez F (1996) Dietary fat clearance in normal subjects is regulated by genetic variation at the apolipoprotein A-IV gene locus. Circulation 94 (Suppl. I): 266 (Abstract)
134. Simon JA, Fong J, Bernert JT Jr, Browner WS (1996) Relation of smoking and alcohol consumption to serum fatty acids. Am J Epidemiol 144: 325-34
135. Hegele RA, Evans AJ, Tu L, Ip G, Brunt JH, Connelly PW (1994) A gene-gender interaction affecting plasma lipoproteins in a genetic isolate. Arterioscler Thromb 14: 671-678
136. Von Eckardstein A, Funke H, Chirazi A, Chen-Haudenschild C, Schulte H, Schönfeld R, Köhler E, Schwarz S, Steinmetz A, Assmann G (1994) Sex-specific effects of the glutamine/histidine polymorphism in apo A-IV on HDL metabolism. Arterioscler Thromb 14: 1114-1120
137. Clifton PM, Nestel PJ (1992) Influence of gender, body mass index, and age on response of plasma lipids to dietary fat plus cholesterol. Arterioscler Thromb 12: 955-962
138. Fisher RM, Mailly F, Peacock RE, Hamsten A, Seed M, Yudkin JS, Beisiegel U, Feussner G, Miller G, Humphries SE, Talmud PJ (1995) Interaction of the Iipoprotein lipase asparagine 291 → serine mutation with body mass index determines elevated plasma triacylglycerol concentrations: A study in hyperlipidemic subjects, myocardial infarction survivors, and healthy adults. J Lipid Res. 36: 2104-2112
139. Arner P (1997) Is familial combined hyperlipidemia a genetic disorder of adipose tissue? Curr Opin Lipidol 8: 89-94
140. Lopez-Miranda J, Ordovas JM, Ostos MA, Castro P, Marin C, Lopez-Segura F, Jansen S, Salas J, Blanco A, Jimenez-Pereperez J, Perez-Jimenez F (1995) Effects of the human apolipoprotein A-I promoter G/A mutation on postprandial Iipoprotein metabolism. Circulation 92 (Suppl. I): 156 (Abstract).